KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$90.0 million.

  • Bristol Myers Squibb's Change in Account Payables fell 11740.81% to -$90.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.0 million, marking a year-over-year decrease of 10108.7%. This contributed to the annual value of -$2.0 million for FY2025, which is 10108.7% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Change in Account Payables of -$90.0 million as of Q4 2025, which was down 11740.81% from $160.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Change in Account Payables registered a high of $517.0 million during Q4 2024, and its lowest value of -$374.0 million during Q3 2024.
  • In the last 5 years, Bristol Myers Squibb's Change in Account Payables had a median value of -$3.0 million in 2022 and averaged $36.7 million.
  • The largest annual percentage gain for Bristol Myers Squibb's Change in Account Payables in the last 5 years was 71304.35% (2023), contrasted with its biggest fall of 76842.11% (2023).
  • Over the past 5 years, Bristol Myers Squibb's Change in Account Payables (Quarter) stood at $226.0 million in 2021, then surged by 79.2% to $405.0 million in 2022, then grew by 9.63% to $444.0 million in 2023, then increased by 16.44% to $517.0 million in 2024, then crashed by 117.41% to -$90.0 million in 2025.
  • Its Change in Account Payables was -$90.0 million in Q4 2025, compared to $160.0 million in Q3 2025 and $13.0 million in Q2 2025.